EuroPerio7: Prof. Dr. Wim Teughels Catholic University Leuven, Department of Periodontology, Research Group for Microbial Adhesion, Leuven, Belgium share the results from a study on the clinical and microbiological efficacy of Lactobacillus reuteri Prodentis as an adjunct to periodontal therapy.
Embed this video on another site
Link to this video
BioGaia is a healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri, which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com If you need more information about BioGaia and our products please visit our website or download our press kit from: http://www.biogaia.com/press-material
Managing Director
